Cryptosporidiosis is a diarrheal disease caused by microscopic parasites named “Cryptosporidium” that can live in intestine of humans and animals. These parasites are passed through the stool of an infected animal or person. Both the parasite and disease are usually called “Crypto”. Outer shell of the parasite offers protection and allows it to persist outside the body for a long time. This outer layer also makes it resilient to chlorine-based disinfectants.
Read Report Overview – https://www.transparencymarketresearch.com/cryptosporidium-diagnostic-testing-market.html
In the past few years, Crypto has become the most common cause of water borne diseases which includes both drinking and recreational water. The parasite is found in every region of the world. Currently, several species of Cryptosporidium exist that have the ability to infect wide range of animals and humans. Cryptosporidium parvum and Cryptosporidium hominis are the most prevalent species of Cryptosporidium that cause disease in humans. However, infections caused by other species such as C. muris C. meleagridis, C. felis, and C. canis have also been reported across the globe.
The global cryptosporidium diagnostic testing market is projected to grow at a rapid pace in the next few years. The cryptosporidium diagnostic testing market is anticipated to be driven by increase in infections caused by water borne diseases, mandatory laws by government to check water quality and purity, and rise in importance of water testing activities in many verticals of the industry.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=58995
Additionally, factors such as climate change which alters the quality or supply of water, rise in demand for rapid diagnostic tests, innovation in techniques to develop better diagnostic assays, increase in geriatric population, poor supply water with less water testing facilities in developing countries, and surge in initiatives by government and private bodies to spread awareness about waterborne diseases are likely to drive the global cryptosporidium diagnostic testing market.
For example, countries such as Australia and New Zealand monitor the efficacy of health interventions for climate changes. Development of water treatment and other prevention measures are likely to diminish the effects of climate change on the incidence of cryptosporidiosis. Conventional water testing methods are generally labor intensive and also involve the possibility of contamination due to human error.
Technological advancements such as automation & digitization are projected to drive the global cryptosporidium diagnostic testing market. However, less accuracy of some of the tests, high cost, and availability of products in specific regions are the factors anticipated to hamper the growth of the global cryptosporidium diagnostic testing market.
Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=58995
The global cryptosporidium diagnostic testing market can be segmented based on type of test and end-user. In terms of type of test, the global cryptosporidium diagnostic testing market can be divided into acid-staining test, stool culture, and others. Based on end-user, the global cryptosporidium diagnostic testing market can be classified into hospitals, commercial/private labs, physician offices, and public health labs.
In terms of region, the global cryptosporidium diagnostic testing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are expected to account for major shares of the global cryptosporidium diagnostic testing market due to high awareness of Cryptosporidiosis and other water related diseases, and initiatives taken by the government & regulatory bodies such as making some of the water tests compulsory in countries such as the U.S., the U.K. and Germany.
Pre Book Cryptosporidium Diagnostic Testing Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=58995<ype=S
Asia Pacific is expected to be one of the most lucrative & rapidly growing markets during the forecast period. Factors driving the cryptosporidium diagnostic testing market in the region are increase in geriatric population which has less immunologic response and prone to these infections, rise in per capita income, adoption of newly developed techniques and assays, and investment by key players.
Major players in the global cryptosporidium diagnostic testing market are Abbott Healthcare, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Cepheid, Inc., Elitech Group, DiaSorin, and Grifols, S.A.
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453